Labcorp at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Labcorp brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 919. Its sessions cover bringing companion diagnostic genomic profiling in-house and pushing residual disease detection further with whole-genome sequencing. The company provides clinical laboratory services and drug development laboratory capabilities.
| Organization | AMP 2026 Attendance |
|---|---|
Labcorp Burlington, NC | |
Clinical laboratory services and drug development laboratory capabilities for physicians, hospitals, pharmaceutical companies and patients. | Booth Exhibiting at Booth 919 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 10:00am–10:50am The Value of Bringing CDx Comprehensive Genomic Profiling In-House: Practical Considerations for Molecular Pathology Labs Bringing kitted companion diagnostic genomic profiling in-house, and what labs gain in samples, data and turnaround. Workshop Thu, Nov 12 12:00pm–12:30pm Pushing the Limits of MRD Detection Through Whole-Genome Sequencing Whole-genome sequencing for tumor-informed residual disease testing, aiming at ultrasensitive ctDNA detection and longitudinal monitoring. |
Instantly find 20 buyers from Labcorp
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction